Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PF-00562271 |
Synonyms | |
Therapy Description |
PF-00562271 is an ATP-competitive inhibitor of FAK and PYK2, which may result in inhibition of cell proliferation and migration, and reduce cell survival (PMID: 18339875, PMID: 23536552, PMID: 22454420). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
PF-00562271 | PF-562271|PF-562,271|PF-271|VS-6062 | FAK inhibitor 15 | PF-00562271 is an ATP-competitive inhibitor of FAK and PYK2, which may result in inhibition of cell proliferation and migration, and reduce cell survival (PMID: 18339875, PMID: 23536552, PMID: 22454420). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|